Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Gender-Specific Predictive Markers of Poor Prognosis for Patients with Acute Myocardial Infarction During a 6-Month Follow-up

  • 55 Accesses

  • 1 Citations

Abstract

Mounting evidence indicates the impact of gender difference on the assessment, treatment, and outcome of patients with acute myocardial infarction (AMI). However, gender-specific prognostic markers of AMI are still lacking. The present study aimed to investigate gender-specific markers of poor prognosis (all-cause mortality or readmission) in a cohort of AMI patients followed up for 6 months. Compared with males (n = 157), females (n = 40) were older and more frequent with previous medical history of hypertension and diabetes mellitus. During the 6-month follow-up, BUN ≥ 7.73 mM, myoglobin ≥ 705.8 ng/mL, and Killip classification 2–4 were identified as the independent predictors of poor prognosis for male AMI patients, while D-dimer ≥ 0.43 mg/L as an independent predictor of poor prognosis in female AMI patients. In conclusion, our data suggest that prognostic markers for AMI patients may differ according to genders. Gender-specific prognostic markers may be useful to guide the risk stratification, clinical therapy, and medications for AMI patients.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., et al. (2016). 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation, 155, 134(10), e123.

  2. 2.

    Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. P., Costa, F., Jeppsson, A., et al. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 39(3), 213–260.

  3. 3.

    Jortveit, J., Govatsmark, R. E., Langorgen, J., Hole, T., Mannsverk, J., Olsen, S., et al. (2016). Gender differences in the assessment and treatment of myocardial infarction. Tidsskrift for den Norske Lægeforening, 136(14–15), 1215–1222.

  4. 4.

    Motiwala, S. R., Sarma, A., Januzzi, J. L., & O'Donoghue, M. L. (2014). Biomarkers in ACS and heart failure: Should men and women be interpreted differently? Clinical Chemistry, 60(1), 35–43.

  5. 5.

    Dey, S., Flather, M. D., Devlin, G., Brieger, D., Gurfinkel, E. P., Steg, P. G., et al. (2009). Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: The global registry of acute coronary events. Heart, 95(1), 20–26.

  6. 6.

    Bugiardini, R., Ricci, B., Cenko, E., Vasiljevic, Z., Kedev, S., Davidovic, G., et al. (2017). Delayed care and mortality among women and men with myocardial infarction. Journal of the American Heart Association, 6(8).

  7. 7.

    Sorensen, N. A., Neumann, J. T., Ojeda, F., Schafer, S., Magnussen, C., Keller, T., et al. (2018). Relations of sex to diagnosis and outcomes in acute coronary syndrome. Journal of the American Heart Association, 7(6).

  8. 8.

    Pagidipati, N. J., & Peterson, E. D. (2016). Acute coronary syndromes in women and men. Nature Reviews. Cardiology, 13(8), 471–480.

  9. 9.

    Poon, S., Goodman, S. G., Yan, R. T., Bugiardini, R., Bierman, A. S., Eagle, K. A., et al. (2012). Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. American Heart Journal, 163(1), 66–73.

  10. 10.

    Berger, J. S., Elliott, L., Gallup, D., Roe, M., Granger, C. B., Armstrong, P. W., et al. (2009). Sex differences in mortality following acute coronary syndromes. JAMA, 302(8), 874–882.

  11. 11.

    Redfors, B., Angeras, O., Ramunddal, T., Petursson, P., Haraldsson, I., Dworeck, C., et al. (2015). Trends in gender differences in cardiac care and outcome after acute myocardial infarction in Western Sweden: A report from the Swedish web system for enhancement of evidence-based Care in Heart Disease Evaluated According to recommended therapies (SWEDEHEART). Journal of the American Heart Association, 4(7).

  12. 12.

    Dreyer, R. P., Ranasinghe, I., Wang, Y., Dharmarajan, K., Murugiah, K., Nuti, S. V., et al. (2015). Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation, 132(3), 158–166.

  13. 13.

    Vaccarino, V., Krumholz, H. M., Yarzebski, J., Gore, J. M., & Goldberg, R. J. (2001). Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Annals of Internal Medicine, 134(3), 173–181.

  14. 14.

    Wu, X., Chen, M., Wang, K., Gao, R., & Li, X. (2019). Gender differences in prognostic markers of all-cause death in patients with acute heart failure: A prospective 18-month follow-up study. Journal of Cardiovascular Translational Research.

  15. 15.

    Hochman, J. S., Tamis, J. E., Thompson, T. D., Weaver, W. D., White, H. D., Van de Werf, F., et al. (1999). Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. The New England Journal of Medicine, 341(4), 226–232.

  16. 16.

    Zhang, Y., Liu, B., Zhao, R., Zhang, S., Yu, X. Y., & Li, Y. (2019). The influence of sex on cardiac physiology and cardiovascular diseases. Journal of Cardiovascular Translational Research.

  17. 17.

    Garcia-Garcia, C., Molina, L., Subirana, I., Sala, J., Bruguera, J., Aros, F., et al. (2014). Sex-based differences in clinical features, management, and 28-day and 7-year prognosis of first acute myocardial infarction. RESCATE II study. Rev Esp Cardiol (Engl Ed), 67(1), 28–35.

  18. 18.

    Albrektsen, G., Heuch, I., Lochen, M. L., Thelle, D. S., Wilsgaard, T., Njolstad, I., et al. (2017). Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromso study 1979-2012. Atherosclerosis, 261, 52–59.

  19. 19.

    Kappert, K., Bohm, M., Schmieder, R., Schumacher, H., Teo, K., Yusuf, S., et al. (2012). Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: Analysis of the Telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease (TRANSCEND) and the ongoing Telmisartan alone and in combination with Ramipril global end point trial (ONTARGET). Circulation, 126(8), 934–941.

  20. 20.

    Peters, S. A., Huxley, R. R., & Woodward, M. (2014). Diabetes as risk factor for incident coronary heart disease in women compared with men: A systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia, 57(8), 1542–1551.

  21. 21.

    Anand, S. S., Islam, S., Rosengren, A., Franzosi, M. G., Steyn, K., Yusufali, A. H., et al. (2008). Risk factors for myocardial infarction in women and men: Insights from the INTERHEART study. European Heart Journal, 29(7), 932–940.

  22. 22.

    Shah, N., Kelly, A. M., Cox, N., Wong, C., & Soon, K. (2016). Myocardial infarction in the “young”: Risk factors, presentation, management and prognosis. Heart, Lung & Circulation, 25(10), 955–960.

  23. 23.

    Barbash, G. I., White, H. D., Modan, M., Diaz, R., Hampton, J. R., Heikkila, J., et al. (1995). Acute myocardial infarction in the young—the role of smoking. The investigators of the international tissue plasminogen activator/streptokinase mortality trial. European Heart Journal, 16(3), 313–316.

  24. 24.

    Granger, C. B., Goldberg, R. J., Dabbous, O., Pieper, K. S., Eagle, K. A., Cannon, C. P., et al. (2003). Predictors of hospital mortality in the global registry of acute coronary events. Archives of Internal Medicine, 163(19), 2345–2353.

  25. 25.

    Rule, A. D., Larson, T. S., Bergstralh, E. J., Slezak, J. M., Jacobsen, S. J., & Cosio, F. G. (2004). Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Annals of Internal Medicine, 141(12), 929–937.

  26. 26.

    Usberti, M., Federico, S., Di Minno, G., Ungaro, B., Ardillo, G., Pecoraro, C., et al. (1985). Effects of angiotensin II on plasma ADH, prostaglandin synthesis, and water excretion in normal humans. The American Journal of Physiology, 248(2 Pt 2), F254–F259.

  27. 27.

    Saygitov, R. T., Glezer, M. G., & Semakina, S. V. (2010). Blood urea nitrogen and creatinine levels at admission for mortality risk assessment in patients with acute coronary syndromes. Emergency Medicine Journal, 27(2), 105–109.

  28. 28.

    Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., et al. (2005). Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. Journal of the American College of Cardiology, 45(11), 1781–1786.

  29. 29.

    Horiuchi, Y., Aoki, J., Tanabe, K., Nakao, K., Ozaki, Y., Kimura, K., et al. (2018). A high level of blood urea nitrogen is a significant predictor for in-hospital mortality in patients with acute myocardial infarction. International Heart Journal, 59(2), 263–271.

  30. 30.

    Wang, S., Qin, L., Wu, T., Deng, B., Sun, Y., Hu, D., et al. (2014). Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury. Medical Science Monitor, 20, 2043–2053.

  31. 31.

    Roych, C., Magioncalda, A., Sanfelici, D., Mattiauda, C., Cavazzana, C., Mellini, M., et al. (1982). Diagnostic and prognostic value of radioimmunologic determination of myoglobin in myocardial infarction. Cardiologia, 27(5), 493–496.

  32. 32.

    Venge, P. (1983). The diagnostic and prognostic value of serum-myoglobin determinations in acute myocardial infarction. Upsala Journal of Medical Sciences, 88(3), 205–211.

  33. 33.

    DeGeare, V. S., Boura, J. A., Grines, L. L., O'Neill, W. W., & Grines, C. L. (2001). Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. The American Journal of Cardiology, 87(9), 1035–1038.

  34. 34.

    Emery, M., Lopez-Sendon, J., Steg, P. G., Anderson Jr., F. A., Dabbous, O. H., Scheuble, A., et al. (2006). Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: The global registry of acute coronary events. American Heart Journal, 152(6), 1015–1021.

  35. 35.

    Khot, U. N., Jia, G., Moliterno, D. J., Lincoff, A. M., Khot, M. B., Harrington, R. A., et al. (2003). Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: The enduring value of Killip classification. JAMA, 290(16), 2174–2181.

  36. 36.

    El-Menyar, A., Zubaid, M., AlMahmeed, W., Sulaiman, K., AlNabti, A., Singh, R., et al. (2012). Killip classification in patients with acute coronary syndrome: Insight from a multicenter registry. The American Journal of Emergency Medicine, 30(1), 97–103.

  37. 37.

    Im, M. S., Kim, H. L., Kim, S. H., Lim, W. H., Seo, J. B., Chung, W. Y., et al. (2016). Different prognostic factors according to left ventricular systolic function in patients with acute myocardial infarction. International Journal of Cardiology, 221, 90–96.

  38. 38.

    Valero-Masa, M. J., Velasquez-Rodriguez, J., Diez-Delhoyo, F., Devesa, C., Juarez, M., Sousa-Casasnovas, I., et al. (2017). Sex differences in acute myocardial infarction: Is it only the age? International Journal of Cardiology, 231, 36–41.

  39. 39.

    Erkol, A., Oduncu, V., Turan, B., Kilicgedik, A., Sirma, D., Gozubuyuk, G., et al. (2014). The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction. Journal of Thrombosis and Thrombolysis, 38(3), 339–347.

  40. 40.

    Tataru, M. C., Heinrich, J., Junker, R., Schulte, H., von Eckardstein, A., Assmann, G., et al. (1999). D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. European Heart Journal, 20(20), 1493–1502.

  41. 41.

    Sarli, B., Akpek, M., Baktir, A. O., Sahin, O., Saglam, H., Arinc, H., et al. (2015). Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction. Herz, 40(3), 507–513.

  42. 42.

    Choi, S., Jang, W. J., Song, Y. B., Lima, J. A., Guallar, E., Choe, Y. H., et al. (2016). D-dimer levels predict myocardial injury in ST-segment elevation myocardial infarction: A cardiac magnetic resonance imaging study. PLoS One, 11(8), e0160955.

  43. 43.

    Simes, J., Robledo, K. P., White, H. D., Espinoza, D., Stewart, R. A., Sullivan, D. R., et al. (2018). D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease. Circulation, 138(7), 712–723.

  44. 44.

    Siennicka, A., Jastrzebska, M., Smialkowska, K., Oledzki, S., Chelstowski, K., Klysz, M., et al. (2018). Gender differences in hemostatic and inflammatory factors in patients with acute coronary syndromes: A pilot study. Journal of Physiology and Pharmacology, 69(1), 91–98.

Download references

Author information

Correspondence to Ming Luo.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Research Involving Human Participants

This study had enrolled 206 consecutive patients diagnosed and hospitalized for the first visit of AMI in Cardiology Department of Tongji Hospital affiliated to Tongji University (Shanghai, China) from October 2015 to August 2017. All patients were diagnosed according to Guidelines for the Diagnosis and Treatment of AMI in China. Patients with malignant tumor and/or uncontrolled systemic diseases including kidney diseases and renal dysfunction were excluded. The present study was approved by the independent Ethics Committee of Tongji Hospital affiliated to Tongji University (Shanghai, China). Each participant signed informed consent form at enrollment.

Informed Consent

Each participant had signed informed consent form.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Associate Editor Associate Editor Yihua Bei oversaw the review of this article

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, P., Yao, J., Xie, Y. et al. Gender-Specific Predictive Markers of Poor Prognosis for Patients with Acute Myocardial Infarction During a 6-Month Follow-up. J. of Cardiovasc. Trans. Res. 13, 27–38 (2020). https://doi.org/10.1007/s12265-019-09946-6

Download citation

Keywords

  • Gender
  • Myocardial infarction
  • Prognostic marker